Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-360947
Filing Date
2018-12-28
Accepted
2018-12-28 16:14:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A (AMENDMENT NO. 2) d675024dsc13ga.htm SC 13G/A 25037
  Complete submission text file 0001193125-18-360947.txt   26751
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Subject) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13G/A | Act: 34 | File No.: 005-80101 | Film No.: 181257573
SIC: 2834 Pharmaceutical Preparations